Psychiatrienet - User contributions [en]

Clonazepam

2013-03-21T12:58:04Z

Mathilde:

{{Drug
| name = clonazepam
| type = benzodiazepine
| group = benzodiazepine
| CAS = 1622-61-3
| ChemSpiderID = 2700
| ATC = N03AE01
| pubchem = 2802
| DrugBank = APRD00054
| medscape = 14403
| drugscom = clonazepam
| ftk = clonazepam
| equivalent = 20
| equivalent_ref = <ref>[http://www.ntvg.nl/publicatie/kiezen-voor-de-juiste-benzodiazepine Vinkers C, Tijdink J, Luykx J, Vis R Kiezen voor de juiste benzodiazepine. Nederlands Tijdschrift voor Geneeskunde. 2012;156:A4900]</ref><ref>[http://www.ncbi.nlm.nih.gov/pubmed/10379424 Chouinard G, Lefko-Singh K, Teboul E. Metabolism of Anxiolytics and Hypnotics: Benzodiazepines, Buspirone, Zoplicone, and Zolpidem. Cell Mol Neurobiol. 1999 Aug;19(4):533-52.]</ref> | comparison = diazepam
| avail = 90
| avail_ref = <ref name="informatorium">{{KNMP|clonazepam}}</ref>
| halflife = 20-60
| halflife_ref = <ref name="informatorium" />
| ct = 12.5
| ct_ref = <ref name="informatorium" />
| metabolites = 5
| metabolites_ref = <ref name="informatorium" />
| administration = O,IV,OM,R
| DDD = 8
| DDD_ref = <ref>{{WHOCC|N03AE01}}</ref>
| dmax = 20
| dmax_ref = <ref>{{FTK|clonazepam}}</ref>
| ctox =
| ctox_ref =
| <includeonly> isswitch = 1</includeonly>
}}

Clonazepam

2013-03-21T12:55:49Z

Mathilde:

{{Drug
| name = clonazepam
| type = benzodiazepine
| group = benzodiazepine
| CAS = 1622-61-3
| ChemSpiderID = 2700
| ATC = N03AE01
| pubchem = 2802
| DrugBank = APRD00054
| medscape = 14403
| drugscom = clonazepam
| ftk = clonazepam
| equivalent = 20
| equivalent_ref = <ref>[http://www.ntvg.nl/publicatie/kiezen-voor-de-juiste-benzodiazepine Vinkers C, Tijdink J, Luykx J, Vis R Kiezen voor de juiste benzodiazepine. Nederlands Tijdschrift voor Geneeskunde. 2012;156:A4900]</ref><ref>[http://www.ncbi.nlm.nih.gov/pubmed/10379424 Chouinard G, Lefko-Singh K, Teboul E. Metabolism of Anxiolytics and Hypnotics: Benzodiazepines, Buspirone, Zoplicone, and Zolpidem. Cell Mol Neurobiol. 1999 Aug;19(4):533-52.</ref> | comparison = diazepam
| avail = 90
| avail_ref = <ref name="informatorium">{{KNMP|clonazepam}}</ref>
| halflife = 20-60
| halflife_ref = <ref name="informatorium" />
| ct = 12.5
| ct_ref = <ref name="informatorium" />
| metabolites = 5
| metabolites_ref = <ref name="informatorium" />
| administration = O,IV,OM,R
| DDD = 8
| DDD_ref = <ref>{{WHOCC|N03AE01}}</ref>
| dmax = 20
| dmax_ref = <ref>{{FTK|clonazepam}}</ref>
| ctox =
| ctox_ref =
| <includeonly> isswitch = 1</includeonly>
}}

Clonazepam

2013-03-21T12:54:43Z

Mathilde:

{{Drug
| name = clonazepam
| type = benzodiazepine
| group = benzodiazepine
| CAS = 1622-61-3
| ChemSpiderID = 2700
| ATC = N03AE01
| pubchem = 2802
| DrugBank = APRD00054
| medscape = 14403
| drugscom = clonazepam
| ftk = clonazepam
| equivalent = 20
| equivalent_ref = <ref>[http://www.ntvg.nl/publicatie/kiezen-voor-de-juiste-benzodiazepine] C. Vinkers, J. Tijdink, J. Luykx, R. Vis Kiezen voor de juiste benzodiazepine. Nederlands Tijdschrift voor Geneeskunde. 2012;156:A4900]</ref><ref>[http://www.ncbi.nlm.nih.gov/pubmed/10379424] Chouinard G, Lefko-Singh K, Teboul E. Metabolism of Anxiolytics and Hypnotics: Benzodiazepines, Buspirone, Zoplicone, and Zolpidem. Cell Mol Neurobiol. 1999 Aug;19(4):533-52.</ref> | comparison = diazepam
| avail = 90
| avail_ref = <ref name="informatorium">{{KNMP|clonazepam}}</ref>
| halflife = 20-60
| halflife_ref = <ref name="informatorium" />
| ct = 12.5
| ct_ref = <ref name="informatorium" />
| metabolites = 5
| metabolites_ref = <ref name="informatorium" />
| administration = O,IV,OM,R
| DDD = 8
| DDD_ref = <ref>{{WHOCC|N03AE01}}</ref>
| dmax = 20
| dmax_ref = <ref>{{FTK|clonazepam}}</ref>
| ctox =
| ctox_ref =
| <includeonly> isswitch = 1</includeonly>
}}

Clonazepam

2013-03-21T12:52:49Z

Mathilde:

{{Drug
| name = clonazepam
| type = benzodiazepine
| group = benzodiazepine
| CAS = 1622-61-3
| ChemSpiderID = 2700
| ATC = N03AE01
| pubchem = 2802
| DrugBank = APRD00054
| medscape = 14403
| drugscom = clonazepam
| ftk = clonazepam
| equivalent = 20
| equivalent_ref = <ref>[http://www.ntvg.nl/publicatie/kiezen-voor-de-juiste-benzodiazepine Kiezen voor de juiste benzodiazepine. Nederlands Tijdschrift voor Geneeskunde. 2012;156:A4900]</ref><ref>Chouinard G, Lefko-Singh K, Teboul E. Metabolism of Anxiolytics and Hypnotics: Benzodiazepines, Buspirone, Zoplicone, and Zolpidem. Cell Mol Neurobiol. 1999 Aug;19(4):533-52.</ref> | comparison = diazepam
| avail = 90
| avail_ref = <ref name="informatorium">{{KNMP|clonazepam}}</ref>
| halflife = 20-60
| halflife_ref = <ref name="informatorium" />
| ct = 12.5
| ct_ref = <ref name="informatorium" />
| metabolites = 5
| metabolites_ref = <ref name="informatorium" />
| administration = O,IV,OM,R
| DDD = 8
| DDD_ref = <ref>{{WHOCC|N03AE01}}</ref>
| dmax = 20
| dmax_ref = <ref>{{FTK|clonazepam}}</ref>
| ctox =
| ctox_ref =
| <includeonly> isswitch = 1</includeonly>
}}

Clonazepam

2013-03-21T12:47:19Z

Mathilde:

{{Drug
| name = clonazepam
| type = benzodiazepine
| group = benzodiazepine
| CAS = 1622-61-3
| ChemSpiderID = 2700
| ATC = N03AE01
| pubchem = 2802
| DrugBank = APRD00054
| medscape = 14403
| drugscom = clonazepam
| ftk = clonazepam
| equivalent = 20
| equivalent_ref = <ref>[http://www.ntvg.nl/publicatie/kiezen-voor-de-juiste-benzodiazepine Kiezen voor de juiste benzodiazepine. Nederlands Tijdschrift voor Geneeskunde. 2012;156:A4900]</ref>
| comparison = diazepam
| avail = 90
| avail_ref = <ref name="informatorium">{{KNMP|clonazepam}}</ref>
| halflife = 20-60
| halflife_ref = <ref name="informatorium" />
| ct = 12.5
| ct_ref = <ref name="informatorium" />
| metabolites = 5
| metabolites_ref = <ref name="informatorium" />
| administration = O,IV,OM,R
| DDD = 8
| DDD_ref = <ref>{{WHOCC|N03AE01}}</ref>
| dmax = 20
| dmax_ref = <ref>{{FTK|clonazepam}}</ref>
| ctox =
| ctox_ref =
| <includeonly> isswitch = 1</includeonly>
}}

Clonazepam

2013-03-21T12:45:27Z

Mathilde:

Clonazepam

2013-03-19T15:24:40Z

Mathilde:

{{Drug
| name = clonazepam
| type = xbenzodiazepine
| group = xbenzodiazepine
| CAS = 1622-61-3
| ChemSpiderID = 2700
| ATC = N03AE01
| pubchem = 2802
| DrugBank = APRD00054
| medscape = 14403
| drugscom = clonazepam
| ftk = clonazepam
| equivalent = 20
| equivalent_ref = {{HandoutPapendal}}
| comparison = diazepam
| avail = 90
| avail_ref = <ref name="informatorium">{{KNMP|clonazepam}}</ref>
| halflife = 20-60
| halflife_ref = <ref name="informatorium" />
| ct = 12.5
| ct_ref = <ref name="informatorium" />
| metabolites = 5
| metabolites_ref = <ref name="informatorium" />
| administration = O,IV,OM,R
| DDD = 8
| DDD_ref = <ref>{{WHOCC|N03AE01}}</ref>
| dmax = 20
| dmax_ref = <ref>{{FTK|clonazepam}}</ref>
| ctox =
| ctox_ref =
| <includeonly> isswitch = 1</includeonly>
}}

Flupenthixol LA-Olanzapine LA

2013-03-01T15:26:16Z

Mathilde:

{{Drugswitch
| from = Flupenthixol_LA
| to = Olanzapine_LA
| stop = {{Lastinjection}}
| start = {{StartDepot2}}
| info = {{caveQT}}
* {{olanzapine-oral}}
| view = StopDepotStartArip.jpg
}}

Fluphenazine LA-Olanzapine LA

2013-03-01T15:25:37Z

Mathilde:

{{Drugswitch
| from = Fluphenazine_LA
| to = Olanzapine_LA
| stop = {{Lastinjection}}
| start = {{StartDepot2}}
| info = {{caveQT}}
* {{olanzapine-oral}}

| view = StopDepotStartArip.jpg
}}

Fluphenazine LA-Olanzapine LA

2013-03-01T15:25:15Z

Mathilde:

{{Drugswitch
| from = Fluphenazine_LA
| to = Olanzapine_LA
| stop = {{Lastinjection}}
| start = {{StartDepot2}}
| info = {{caveQT}}
* {{olanzapine-oral}}
| view = StopDepotStartArip.jpg
}}

Fluphenazine LA-Olanzapine LA

2013-03-01T15:24:49Z

Mathilde:

{{Drugswitch
| from = Fluphenazine_LA
| to = Olanzapine_LA
| stop = {{Lastinjection}}
| start = {{StartDepot2}}
| info = {{caveQT}}
| caveat
* {{olanzapine-oral}}
| view = StopDepotStartArip.jpg
}}

Template:Olanzapine-oral

2013-03-01T15:10:13Z

Mathilde:

It is safer first to switch to oral [[olanzapine]] and afterwards to olanzapine pamoate. See [http://wiki.psychiatrienet.nl/index.php/SwitchAntipsychotics Switchtable]

Template:Olanzapine-oral

2013-03-01T15:08:39Z

Mathilde:

It is safer first to switch to oral [[olanzapine]] and afterwards to olanzapine pamoate. See Switchtable.

Template:Olanzapine-oral

2013-03-01T15:08:17Z

Mathilde:

It is safer first to switch to oral [[olanzapine]] and afterwards to olanzapine pamoate. See [Switchtable].

Switch

2013-03-01T15:06:30Z

Mathilde: Created page with 'http://wiki.psychiatrienet.nl/index.php/SwitchAntipsychotics'

http://wiki.psychiatrienet.nl/index.php/SwitchAntipsychotics

Template:Olanzapine-oral

2013-03-01T15:06:10Z

Mathilde:

It is safer first to switch to oral [[olanzapine]] and afterwards to olanzapine pamoate. See [[Switch]].

Project:Background

2013-03-01T14:55:03Z

Mathilde: /* Acknowledgements */

__NOTOC__
More information and/or sources of switching antidepressants and antipsychotics

===Mission statement===
To improve independently psychopharmacotherapy and medication safety for all patients.

===Editor-in-chief===
'''Walter Broekema (1953) is the founder and editor-in-chief of this WIKI'''.
[[image:WB paraplu.JPG|left|135px|Walter Broekema]]
He is hospital pharmacist and head of the clinical pharmacy department at [http://www.ggzcentraal.nl GGz Centraal] in Amersfoort, The Netherlands. He also has pharmaceutical responsibility for a number of other Mental Health Institutions. He graduated as a pharmacist in 1979 and gained his specialisation `hospital pharmacist' in 1991. He has worked at university and community pharmacy. He is active in several organisations inside and outside the hospital, nationally and internationally. He is president of the Special Interest Group Psychiatry of the Dutch Association of Hospital Pharmacists (NVZA/KNMP). He initiated the ATC-drug-distribution robot, started an early audiovisual quality manual and is active in several E-projects like this one. One of his favourites is multidisciplinary cooperation and education. He actively participates in (inter)national conferences. <br />Conflict of interests: no pharmaceutical companies nor financial interest is involved. Declared 2013.
<br clear="all">

===Acknowledgements===
* ''' Ralph de Backer, MSc, PharmD''': benzodiazepines
* ''' Sietske Brouwer, BSc, coming up: MSc, PharmD''': maintenance
* ''' Jaap Kerkvliet, MSc, PharmD''': flagged revisions
* ''' Klaas Kooistra, MSc, PharmD''': moodstabilizers
* ''' Hélène Lichtenberg,MSc, PharmD''': hypericum switches
* ''' Ashni Lo-Kim-Lin, MSc, PharmD''': general
* ''' Lenneke Minjon, MSc, PharmD''': plain stopping antidepressants
* ''' Alexandra Mulder, MSc, PharmD''': antidepressants
* ''' Verena Mulder, MSc, PharmD''': antipsychotics
* ''' Mariska de Roo, PharmD''': general & authorization
* ''' Arent Storm, MSc''': website design & realization, technical and methodological supervision, benzo convertor
* ''' Arend Veeninga †, psychiatrist, PhD''': tester user interface
* ''' Mathilde van Veggel, BSc, coming up: MSc, PharmD''': maintenance

=== Work in progress ===
We are gradually improving the tables by adding more references, graphics etc. This will take time.